GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AT-1501 | AT1501
Compound class:
Antibody
Comment: Tegoprubart (AT-1501) is a monoclonal antibody that targets human CD40 ligand (CD40LG; CD154). Signalling via the CD40-CD40L costimulatory pathway is a recognized mechanism that can drive transplant (graft) rejection and inhibition/blockade of this pathway is considered as a potential therapeutic approach to achieve transplant tolerance and graft survival [3-5]. Tegoprubart is modified to prevent FcγRII receptor-mediated platelet activation and reduce the risk of drug-induced thromboembolic events.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12545 | tegoprubart |
Synonyms ![]() |
| AT-1501 | AT1501 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1433 |
| Other databases | |
| Search PubMed clinical trials | tegoprubart |
| Search PubMed titles | tegoprubart |
| Search PubMed titles/abstracts | tegoprubart |